Approach To Cough

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 33

APPROACH TO COUGH

BY
DR SABNA
FIRST YEAR PGT
DEPT OF CHEST MEDICINE
COUGH
• Cough is a protective mechanism to facilitatae
the removal of mucus,noxious substances or
pathogens from the airways& lungs.
• Impairment can be harmful or even fatal
• Usually start as a deep inspiration followed by
expiration against a closed glottis, which then
opens with an expulsive flow of air.
• Can be reflex or voluntary.
MECHANICS OF COUGHING
• INSPIRATORY PHASE: deep inspiration
through widely opened glottis. Large lung
volume provides better mechanical efficiency
for expiratory muscles as they are stretched
&stronger elastic recoil of lung aid expiration
• COMPRESSIVE PHASE: Lasts for 200ms.glottis
closes while expiratory muscles contract &
intrapleural& intra-alveolar pressures rise
rapidly ( 40-400 cm H2O)
• EXPIRATORY PHASE :
• May be long lasting with a large expiratory
tidal volume,or interrupted by glottic closures
into series of short expiratory efforts.
• Effectiveness of cough depends on peak
airflow & therefore be greater with larger
elastic recoil of lung which creates driving
pressure, & a greater stiffness of central
airways, which prevents dynamic collapse.
NEUROBIOLOGY OF COUGH
SENSORY RECEPTORS
• Structures innervated by Vagus nerve.
• Include larynx, tracheobronchial tree, lower
part of oropharynx, tympanic membrane and
external auditory meatus.
• 2 types of cough evoking sensory nerve fibers:
vagal nociceptors & vagal mechanoreceptors
• Vagal nociceptors : respond to
bradykinin ,prostaglandins ,leukotrienes ,
proteases & cytokines, noxious irritants like
capsaicin, acid, nicotine & acrolein
• Vagal mechanoreceptors: stimuli include acid
solution, hypotonic solution including inhaled
fog, mechanical stimulation by catheter,
mucus or dust.
MEMBRANE RECEPTORS OR CHANNELS FOR
COUGH TRANSDUCTION:
• Transient receptor potential channels(TRP)
• Tetradoxin insensitive voltage gated sodium
channel
• G protein coupled receptors
• Mechanically gated membrane ion channel
• Acid sensing ion channel (ASIC)
• Voltage sensitive ion channel like NaV1.7
• P2X2& P2X3 channels
APPROACH TO PATIENT WITH COUGH
• COUGH: acute - <3 weeks
subacute -3-8 weeks
chronic- >8 weeks
• Goal: 1) determine severity
2)assess possible cause
3)plan investigations & treatment
COMMON CAUSES OF COUGH
APPROACH TO ADULT WITH COUGH
COUGH IN CHILDREN
ACUTE COUGH
• Acute may suggest:
Upper RT
• Common cold –Self limiting ,resolves in 2 wks,
• Sinusitis
Lower RT
• Pneumonia
• Bronchitis
• Exacerbation of COPD, asthma
• Inhalation of bronchial irritant (eg, smoke or fumes)
SUBACUTE COUGH
• Commonly due to prior infection
• Exacerbation of underlying disease like COPD,
asthma, upper airway cough syndrome
• pertussis
CHRONIC COUGH
• COPD
• Pulmonary TB
• Asthma
• Gastro-esophageal reflux
• Psychogenic
• Upper airway cough syndrome (UACS)
• postnasal drip (PND)
• Bronchiectasis
• Drugs (eg, ACE inhibitors)
• Lung malignancy
• Cardiac failure / pulmonary edema
• Pulmonary embolism
ASSOCIATED SYMPTOMS
• Fever, recent symptoms, SOB – Pneumonia
• History of smoking with intermittent sputum –COPD
• Daily purulent sputum for long periods , or whooping
cough in childhood , recurrent hemoptysis -
bronchiectasis
• Persistant cough especialy in smokers , any
hemopstysis , pneumonia that fail to clear in 4-6wks,
LOA ,LOW - Lung cancer
• Heartburn or regurgitation of acid after eating,
bending or lying ,nocturnal as well as daytime
cough –oesophageal reflux
• Postnasal drip , sinus congestion , headache –
UACS
• Persistant dry cough with excertional SOB-ILD
• Long history with negative signs and
investigations-idiopathic cough
• Wheezing
episodic, bilateral & polyphonic - asthma
Monophonic –intraluminal obstruction-fb/tumor
• Pleuritic chest pain- Pleural effusion, Pneumonia
• Joint pain, dry eyes, LN enlargement -SLE,
SJOGREN (with interstitial lung dss)
• Worse in morning- COPD
• H/o stroke, neurogenic dysphagia-ASPIRATION
PNEUMONIA
COUGH WITH SPUTUM
• Frequency of sputum (How frequent?)
• Quantity of sputum (How much?)
• Appearance of sputum
• Colour of sputum
• Is there any blood in the sputum

• “”””””
“’;
• ;
COLOUR:
• Clear (mucoid) : COPD or bronchectasis
without current infection.
• Yellow(mucopurulent): acute LRTI or asthma.
• Green(purulent): current infection-acute
disease or exacerbation of chronic disease.
• Red(rusty):pneumococcal pneumonia
• Pink(serous or frothy) : acute pulmonary
edema.
CONSISTENCY:
• An increase in stickiness or viscosity:
exacerbation of bronchiectasis.
• Large volume of frothy secretion over week or
months : uncommon bronchoalveolar cell
carcinoma.
• Firm plug : asthma

• Foul smelling sputum : lung abscess


HEMOPTYSIS :
• If with purulent and long standing sputum
a. CHRONIC BRONCHITIS (small amount of blood)
b. BRONCHIECTASIS (large amount of blood)
• If with fever, recent onset, SOB : PNEUMONIA
• If LOA, LOW, H/O smoking : BRONCHIAL
CARCINOMA
• If sputum is pink in color and frothy : PULMONARY
EDEMA
• If sudden onset
a. PULMONARY EMBOLISM
b. ACUTE RT INFECTIONS
• If had contact with TB patients / HIV status : TB
• If with long history of SOB
a. CHRONIC LUNG DSS
b. MITRAL STENOSIS
• If with hematuria, proteinuria
a. GOODPASTURE SYNDROME,
b. WEGENER'S GRANULOMATOSIS (h/o sinusitis)
• If with other bleeding sites
a. COAGULATION DISORDER
b. USE OF ANTICOAGULANTS
Character of cough

• Lack of the usual explosive beginning may


indicate vocal cord paralysis (the 'bovine'
cough).
• A muffled, wheezy, ineffective cough suggests
obstructive pulmonary disease.
• A very loose productive cough suggests
excessive bronchial secretions due to chronic
bronchitis, pneumonia or bronchiectasis.
• A dry, irritating cough may occur with chest
infection,asthma,carcinoma of bronchus or acid
irritation of lungs in GORD.It is also typical of
cough produced by ACE-I
• A barking or croupy cough may suggest problem
with URT or pertussis infection.
Cough hypersensitivity syndrome
• Abnormal state of chronic coughing accompanied by other
sensations like persistent or intermittent tickling, irritating
sensation, rawness or itch or a chocking sensation in throat
with repeated throat clearing, chest tightness, hoarse voice
and dysphagia.
• Triggers include change in temprature,taking a deep
breath,laughing,talking,smoking,aerosol spray and perfumes.
• It is due to increased sensitivity called peripheral
sensitisation which is related to neuroplasticity in vagal
sensory fibres.
• Can also be accompanied by central sensitisation.
COUGH SUPPRESSION THERAPIES
NON PHARMACOLOGICAL PHARMACOLOGICAL
• Speech pathology • Antitussive therapy
management • Neuromodulators
• Expectorants
• Mucolytics –
• Include breathing exercise, acetylcysteines,bromhexine
vocal & laryngeal hygeine & methylcysteine: reduces
training & viscosity in patients with
psychoeducational chronic bronchitis.
counselling.
ANTI TUSSIVES
Narcotic Non narcotic
• Include morphine , • Dextromethorphan
diamorphine and codeine. • Should be avoided in
• At effective dose they cause children.
sedation, physical • At higher doses causes
dependance, respiratory dizziness,nausea,vomiting
depression and constipation and headache
• Levodropropizine-cause
peripheral inhibition of
sensory cough receptors.
NEUROMODULATORS
• Effective in idiopathic or refractory cough.
• Centrally acting : amitriptyline ,gabapentine
morphine.
• Amitryptiline & gabapentine have central
aminoceptive action & modulate presynaptic
N-methyl-D-aspartate receptors, leading to
reduced transmitter release & postsynaptic
excitability.
POTENTIAL NEUROMODULATORS
• New cough suppressant in development include
blockers of ion channels on vagal afferent endings
and centrally acting agents.
• P2X2/3 antagonist gefapixant –currently in phase 3.
• Centrally acting agonist of the alpha 7 nicotinic
acetyl choline receptor-under development
• Alpha 7 cholinergic receptor agonists acting on
central pathway that mediate cough inhibition-
under development
• Centrally acting neurokinin 1 recptor antagonist-
phase 2 trial

You might also like